Mitral valve disease is a condition that affects the mitral valve, causing blood to leak backward or flow too slowly, and can ...

Mitral valve annuloplasty devices are expected to see the highest growth in the region. Increased investments in healthcare ...

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

In a groundbreaking series of surgeries, doctors at Duke Health have successfully performed the world's first living mitral ...

Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR) but its impact is not ...

Capstan Medical’s robot platform has been used for the first in-human robotic assisted transcatheter mitral valve replacement ...

Three girls with major heart problems are thriving after one received a donor heart and then gave healthy valves from her original heart to two other girls. The “domino” heart surgeries by a team at ...

"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Tricuspid regurgitation (TR) is common in patients with atrial functional mitral regurgitation (AFMR). However, very few studies have explored its clinical characteristics, determinants, and ...

ST. LOUIS — Dr. Scally, a cardiothoracic surgeon with Prairie Cardiovascular in O’Fallon, Illinois, explains mitral valve disease, a condition that affects the mitral valve, which controls ...

Capstan Medical announced its first in-human cardiac valve replacements using its catheter-based robotic surgical platform.